Back to search results

Comparing Reticulocyte Hemoglobin and Transferrin Saturation to Guide Iron Treatment in People on Dialysis

Abroad (travel likely)Recruiting

Conditions

Hemodialysis · Anemia in End Stage Renal Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • King Chulalongkorn Memorial Hospital, Pathumwan, Bangkok, Thailand

    Contact: Study coordinator (Jeerath Phannajit M.D.) · jeerath.p@chula.ac.th · 6622564000
    Contact: Principal Investigator (Chalermchon Suttaluang)
    Jeerath Phannajit M.D. (Sub-investigator)
    Paweena Susantitaphong M.D., Ph.D. (Sub-investigator)
Study leads

  • Paweena Susantitaphong M.D, Ph.D.

    Study Chair

    Center of Excellence for Metabolic Bone Disease in CKD patients, Chulalongkorn University

  • Jeerath Phannajit M.D.

    Study Director

    Division of Clinical Epidemiology, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross

  • Chalermchon Suttaluang M.D.

    Principal Investigator

    Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital

View source on ClinicalTrials.gov(opens in a new tab)